The Board of Directors of Liaoning Chengda Biotechnology Co.,Ltd. has authorized a buyback plan on March 11, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.13 CNY | -3.02% |
|
-4.46% | -28.85% |
May. 20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.85% | 1.31B | |
+4.14% | 96.32B | |
+4.21% | 40.77B | |
-11.86% | 33.21B | |
+81.75% | 29.36B | |
-14.25% | 15.7B | |
-7.36% | 13.08B | |
-13.08% | 11.39B | |
+176.65% | 10.47B | |
-57.36% | 8.58B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Liaoning Chengda Biotechnology Co.,Ltd. authorizes a Buyback Plan.